Full Text View
Tabular View
No Study Results Posted
Related Studies
Effectiveness of Home Based Occupational Therapy for Dementia. (ERGODEM)
This study is currently recruiting participants.
Verified by Dresden University of Technology, August 2008
First Received: August 8, 2008   Last Updated: February 26, 2009   History of Changes
Sponsors and Collaborators: Dresden University of Technology
Federal Ministry of Health, Germany
Information provided by: Dresden University of Technology
ClinicalTrials.gov Identifier: NCT00732329
  Purpose

The purpose of this study is to determine if a home based occupational therapy is effective in the treatment of dementia.


Condition Intervention
Dementia
Behavioral: Occupational Therapy

MedlinePlus related topics: Dementia
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Parallel Assignment, Efficacy Study
Official Title: Effectiveness of an Optimized Home Based Occupational Therapy for Patients With Dementia.

Further study details as provided by Dresden University of Technology:

Primary Outcome Measures:
  • Alzheimer's Disease Cooperative Study/Activities of Daily Living [ Time Frame: 2 weeks, 3 and 6 months after invention or 9, 19 and 31 weeks after randomization (treatment-as-usual-group) ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • - for patients: cognitive performance, displaying behavioural problems, satisfaction with occupational therapy, costs of occupational therapy - for family care givers: burden, medical condition, life-satisfaction [ Time Frame: 2 weeks, 3 and 6 months after invention or 9, 19 and 31 weeks after randomization (treatment-as-usual-group) ] [ Designated as safety issue: No ]

Estimated Enrollment: 200
Study Start Date: August 2008
Estimated Study Completion Date: March 2010
Estimated Primary Completion Date: January 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
A: Experimental

optimized home based occupational therapy including:

  • diagnostic assessment
  • patient-centered definition of targets involving the care giver
  • occupational therapy
Behavioral: Occupational Therapy

optimized home Based Occupational Therapy including:

  • diagnostic assessment
  • patient-centered definition of targets involving the care giver
  • occupational therapy
B: No Intervention
treatment according to guidelines of German Society for Psychiatry, Psychotherapy and Nervous Diseases (DGPPN) and German Society of Neurology (DGN) without optimized occupational therapy

  Eligibility

Ages Eligible for Study:   55 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Dementia (according to DSM-IV TR)
  2. A score 26 to 12 on the MMSE
  3. Must be 55 or older
  4. Patient is living at home or therapeutical flat sharing
  5. Primary care giver at least 2 days / week available at home
  6. Written informed consent from patient and care giver
  7. German as dominant language

Exclusion Criteria:

  1. Other dementia (p.e. frontotemporal dementia, dementia with Lewy Bodies, Creutzfeldt-Jakob disease, Parkinson's disease or atypical Parkinson's syndromes
  2. Dementia with relevant displaying behavioural problems (neuropsychiatric Inventory; NPI, Subscore ≥ 8)
  3. Depressive episodes (Geriatric Depression Scale, GDS (short version) ≥ 6)
  4. Mental disability
  5. Home Based Occupational Therapy for Dementia within the last 6 months
  6. Impairment of visual and/or acoustic cognition which does not allow Occupational Therapy
  7. Apoplexy with movement disorders which does not allow Occupational Therapy
  8. Severe physical/systemic illnesses (cardio-pulmonal, Hematological or metabolic) which do not allow participating
  9. Recent history of addictive disorder
  10. Intermittent intake of depressant medication, that likely causes an impairment of cognitive performance during the trial
  11. Participation in another clinical trial
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00732329

Contacts
Contact: Vjera Holthoff, Prof. +49351 458 ext 2034 vjera.holthoff@uniklinikum-dresden.de
Contact: Matthias Schützwohl, Dr. +49351 458 ext 5490 matthias.schuetzwohl@uniklinikum-dresden.de

Locations
Germany
Department of Psychiatry and Psychotherapy Recruiting
Dresden, Germany, 01307
Contact: Vjera Holthoff, Prof.     +49 (0)351458 ext 2034     vjera.holthoff@uniklinikum-dresden.de    
Principal Investigator: Vjera Holthoff, Prof.            
Sub-Investigator: Matthias Schützwohl, Dr.            
Sub-Investigator: Thomas Reuster, PD            
Department for Psychiatry, Psychosomatic und Psychotherapy (of "Park-Krankenhaus Leipzig-Südost GmbH") Recruiting
Leipzig, Germany, 04289
Contact: Thomas Kallert, Prof.     0049341 8 64 ext 1260     thomas.kallert@parkkrankenhaus-leipzig.de    
Principal Investigator: Thomas Kallert, Prof.            
Department of Psychiatry, Psychotherapy and Psychosomatic Recruiting
Günzburg, Germany, 89312
Contact: Thomas Becker, Prof.     0049822196     T.Becker@bkh-guenzburg.de    
Principal Investigator: Thomas Becker, Prof.            
Sponsors and Collaborators
Dresden University of Technology
Federal Ministry of Health, Germany
Investigators
Study Chair: Vjera Holthoff, Prof. Department of Psychiatry and Psychotherapy of University Hospital Dresden
  More Information

No publications provided

Responsible Party: Department of Psychiatry and Psychotherapy of University Hospital Dresden ( Prof. Vjera Holthoff )
Study ID Numbers: LT-DEMENZ-44-074
Study First Received: August 8, 2008
Last Updated: February 26, 2009
ClinicalTrials.gov Identifier: NCT00732329     History of Changes
Health Authority: Germany: Ethics Commission

Study placed in the following topic categories:
Delirium, Dementia, Amnestic, Cognitive Disorders
Mental Disorders
Central Nervous System Diseases
Brain Diseases
Dementia
Cognition Disorders
Delirium

Additional relevant MeSH terms:
Delirium, Dementia, Amnestic, Cognitive Disorders
Mental Disorders
Nervous System Diseases
Central Nervous System Diseases
Brain Diseases
Dementia

ClinicalTrials.gov processed this record on May 07, 2009